Merkliste 
 1 Ergebnisse 
 
1

Risankizumab for The Treatment of Moderate-to-Severe Psoria..:

Adis journals on behalf of: (10309791) ; Spyridon Gkalpakiotis (10020831) ; Petra Cetkovska (10020825)...
https://figshare.com/articles/media/Risankizumab_for_The_Treatment_of_Moderate-to-Severe_Psoriasis_Real-Life_Multicenter_Experience_from_The_Czech_Republic/14610570.  , 2021